Litcius/Paper detail

Lateral Flow Immunoassays for Detecting Viral Infectious Antigens and Antibodies

Rowa Y. Alhabbab

2022Micromachines15 citationsDOIOpen Access PDF

Abstract

Abundant immunological assays currently exist for detecting pathogens and identifying infected individuals, making detection of diseases at early stages integral to preventing their spread, together with the consequent emergence of global health crises. Lateral flow immunoassay (LFIA) is a test characterized by simplicity, low cost, and quick results. Furthermore, LFIA testing does not need well-trained individuals or laboratory settings. Therefore, it has been serving as an attractive tool that has been extensively used during the ongoing COVID-19 pandemic. Here, the LFIA strip's available formats, reporter systems, components, and preparation are discussed. Moreover, this review provides an overview of the current LFIAs in detecting infectious viral antigens and humoral responses to viral infections.

Topics & Concepts

VirologyImmunoassayCoronavirus disease 2019 (COVID-19)PandemicAntigenImmunologyAntibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMedicineComputational biologyBiologyInfectious disease (medical specialty)DiseasePathologyOutbreakBiosensors and Analytical DetectionSARS-CoV-2 detection and testingAdvanced biosensing and bioanalysis techniques
Lateral Flow Immunoassays for Detecting Viral Infectious Antigens and Antibodies | Litcius